CRT 2025

LATE-BREAKING CLINICAL SCIENCE | STRUCTURAL I

Moderator(s)

• 

  Mark Reisman, MD, FACC

  Director, Structural Heart Disease
  NYP Cornell
  new york , New York, United States

  Disclosure information not submitted.
• 

  Ran Kornowski, MD

  Chairman, Department of Cardiology
  Rabin Medical Center
  Petach-Tikva, Israel

  Disclosure(s): Medtronics-Cathworks: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Panelist(s)

• 

  Georges Ephrem, MD, MSc, FACP, FACC, FSCAI

  Assistant Professor
  UTHSC
  Memphis, Tennessee, United States

  Disclosure(s): No financial relationships to disclose
• 

  Philippe Généreux, MD

  Director, Valve & Structural Heart Center
  Morristown Medical Center
  Morristown, New Jersey, United States

  Disclosure(s): 4C Medical Technologies, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pi-Cardia: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)
• 

  Sachin S. Goel, MD, FACC, FSCAI

  Medical Director, Structural Heart Interventions
  Houston Methodist DeBakey Heart & Vascular Center
  Houston, Texas, United States

  Disclosure(s): Abbott: Consultant (Ongoing); JC Medical: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W.L. Gore & Associates: Consultant (Ongoing)
• 

  Howard C. Herrmann, MD, FACC, MSCAI

  Section Chief Interventional Cardiology
  Hospital of the University of Pennsylvania
  Philadelphia, Pennsylvania, United States

  Disclosure(s): Abbott: Grant/Research Support (Ongoing); Affluent Medical: Consultant (Ongoing); Caranx: Consultant (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Massachusetts Medical Society: Editorial consultant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing); Microinterventional Devices: Consultant (Ongoing); Shockwave: Grant/Research Support (Ongoing); Wells Fargo: Consultant (Ongoing)
• 

  Thomas Pilgrim, MD

  Attending physician
  University of Bern, Switzerland
  Bern, Bern, Switzerland

  Disclosure(s): Abbott: Grant/Research Support (Terminated); Biotronik: Grant/Research Support (Terminated); Boston Scientific: Consulting Fees (e.g., advisory boards) (Terminated); Edwards Lifesciences LLC: Grant/Research Support (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); HighLife: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Terminated), Grant/Research Support (Terminated)
• 

  Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

  Professor and Clinical Director of Interventional cardiology
  Thoraxcenter
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure(s): Abbott Medical NL BV: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Adjust Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medial Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); AncorValve: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Approxima Srl: Consulting Fees (e.g., advisory boards) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo: Consulting Fees (e.g., advisory boards) (Ongoing); Ladera: Consulting Fees (e.g., advisory boards) (Ongoing); LUMA Vision: Consulting Fees (e.g., advisory boards) (Ongoing); Materialise: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pie Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Polares: Consulting Fees (e.g., advisory boards) (Ongoing); PulseCath BV: Consulting Fees (e.g., advisory boards) (Ongoing); Secure Closure: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Grant/Research Support (Ongoing); Vivasure: Consulting Fees (e.g., advisory boards) (Ongoing)